The options for culturing cell therapies are vast from traditional T-flasks to novel bioreactors that didn't exist 5 years ago. The selection of the culture system during development can sometimes be done based on comfort with a particular system but, at a commercial scale, that system may not be the best fit.
This presentation by George Todorov, Sr. Engineer, Process, lines out the current marketplace and the pros/cons of different systems and will present on Stage 3.
Add George's session to your INTERPHEX 2021 plan!